TianYu Bio-Technology(603717)

Search documents
天域生物(603717) - 2017 Q3 - 季度财报
2017-10-26 16:00
Financial Performance - Operating revenue for the first nine months reached CNY 534,707,277.46, a 13.05% increase year-on-year[7] - Net profit attributable to shareholders increased by 62.00% to CNY 49,614,839.81 compared to the same period last year[7] - Basic earnings per share rose by 32.57% to CNY 0.3134[7] - Total revenue for the first nine months reached CNY 534,707,277.46, an increase of 13.0% compared to CNY 472,985,936.49 in the same period last year[25] - Net profit attributable to the parent company for the first nine months was CNY 49,614,839.81, compared to CNY 30,626,633.93 in the previous year, representing a growth of 62.0%[26] - The company reported an operating profit of CNY 64,654,838.80 for the first nine months, compared to CNY 36,239,101.11 in the previous year, representing an increase of 78.7%[26] - The company reported a total profit of CNY 59,200,452.57 for the first nine months of 2017, compared to CNY 42,254,065.68 in the same period of 2016, reflecting a growth of 40%[30] Assets and Liabilities - Total assets increased by 38.26% to CNY 2,048,680,274.50 compared to the end of the previous year[7] - The total assets as of September 30, 2017, amounted to 2,048,680,274.50, up from 1,481,737,139.52 at the beginning of the year[19] - The company's equity increased significantly, with capital reserves rising to 654,387,263.72, a 413.73% increase due to new share issuance[12] - The company’s total liabilities decreased to 827,352,891.13 from 880,163,961.82, reflecting a strategic reduction in debt[19] - Total liabilities increased to CNY 1,004,001,619.52 from CNY 862,726,484.17, reflecting a growth of 16.3%[23] - Owner's equity totaled CNY 1,181,283,464.23, significantly up from CNY 565,505,554.83, indicating a growth of 108.7%[23] Cash Flow - The net cash flow from operating activities was negative at CNY -202,060,904.37, a decrease of 494.25% compared to the previous year[7] - Cash inflow from operating activities for the first nine months of 2017 was CNY 509,733,511.20, down from CNY 687,294,596.13 in the previous year, a decrease of 26%[33] - The net cash flow from operating activities for the first nine months of 2017 was -¥134,877,593.13, compared to a positive net cash flow of ¥83,888,446.52 in the previous year, reflecting operational challenges[35] - The company reported a cash flow net amount from financing activities of 616,866,159.01, a substantial increase compared to a negative cash flow of 57,393,737.88 in the previous period[13] - Total cash inflow from financing activities reached ¥788,343,457.87, a substantial increase from ¥150,500,000.00 in the previous year, reflecting strong capital raising efforts[34] - The net cash flow from financing activities for the first nine months was ¥650,015,244.15, a recovery from a negative cash flow of -¥102,224,369.28 in the previous year, indicating improved financing conditions[36] Expenses - Total operating costs for the first nine months were CNY 472,570,841.18, up from CNY 436,663,758.63, reflecting a year-over-year increase of 8.2%[26] - Management expenses increased by 35.69% to 58,076,098.12, primarily due to higher salaries for management personnel[13] - Financial expenses for the first nine months of 2017 were CNY 21,240,189.91, down from CNY 25,126,348.90 in the same period last year, a decrease of 15.2%[30] - Sales expenses for Q3 2017 were CNY 4,198,473.97, significantly higher than CNY 1,701,167.01 in Q3 2016, marking an increase of 146.5%[30] Inventory and Investments - The inventory balance reached 1,014,736,263.46, up from 796,494,453.19, indicating a 27.38% increase[17] - Inventory increased to CNY 945,002,390.17 from CNY 772,244,669.16, marking a rise of 22.4%[22] - Total cash outflow from investing activities for the first nine months was ¥516,162,857.54, significantly higher than ¥2,242,077.19 in the previous year, indicating aggressive investment strategies[35] - The net cash flow from investing activities was -¥292,714,329.77, compared to -¥4,015,331.03 in the previous year, highlighting increased investment expenditures[34] - The company raised ¥581,473,109.17 from new investments during the first nine months of 2017, with a notable increase in borrowing to ¥201,870,348.70 from ¥93,000,000.00 in the previous year[35] Market Strategy - The company plans to continue expanding its market presence and investing in new product development to drive future growth[24]
天域生物(603717) - 2017 Q2 - 季度财报
2017-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was CNY 385,782,321.78, representing a 6.77% increase compared to CNY 361,327,961.12 in the same period last year[18]. - The net profit attributable to shareholders of the listed company reached CNY 40,464,916.99, a significant increase of 51.28% from CNY 26,749,140.50 in the previous year[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 39,615,664.77, up 50.24% from CNY 26,367,410.81 year-on-year[18]. - Basic earnings per share increased by 29.69% to CNY 0.2678 compared to the same period last year[19]. - Net profit attributable to shareholders grew by 51.28% due to increased revenue and gross profit from core business operations[19]. - Total revenue for the period reached CNY 385.78 million, a 6.77% increase year-on-year[30]. - Operating income increased by 94.27% to RMB 2,134,958.99 due to increased government subsidies received during the reporting period[34]. - Operating expenses rose by 103.69% to RMB 1,135,582.98 primarily due to increased donation expenditures[34]. - Income tax expenses increased by 110.23% to RMB 12,187,275.55 as a result of higher current income tax during the reporting period[34]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -209,066,156.29, a decline of 426.44% compared to CNY 64,043,646.69 in the same period last year[18]. - Operating cash flow decreased by 426.44% primarily due to reduced collections from landscaping projects and increased payments to suppliers and taxes[19]. - Cash and cash equivalents increased by 264.15% to RMB 536,192,744.12, mainly due to increased cash received from investments[36]. - The company reported a decrease in cash received from sales of goods and services, totaling RMB 280,973,789.28, down 25% from RMB 374,069,240.12 in the previous year[114]. - The total cash inflow from financing activities amounted to 703,769,285.37 RMB, compared to 67,000,000.00 RMB in the prior period[118]. - The net cash flow from financing activities was 658,283,221.81 RMB, a significant improvement from -63,911,551.99 RMB in the previous period[118]. - The total cash and cash equivalents at the end of the period reached 306,976,055.11 RMB, up from 127,735,284.75 RMB at the end of the previous period[118]. Assets and Liabilities - Total assets increased by 40.72% to CNY 2,085,150,344.18 from CNY 1,481,737,139.52 at the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were CNY 1,211,263,941.51, an increase of 101.67% from CNY 600,612,924.52 at the end of the previous year[18]. - The company's asset scale of Shanghai Tianxia reached 78,234,175.31 RMB, while net assets were 66,046,437.77 RMB[43]. - The company's debt guarantee amount exceeded 50% of its net assets, indicating a high leverage situation[62]. - The total liabilities decreased slightly to ¥872,958,189.89 from ¥880,163,961.82, a reduction of about 0.2%[101]. Shareholder and Equity Information - The company issued 4,317,790 shares at a price of CNY 14.63 per share, increasing total shares to 17,271,160[73]. - The total number of ordinary shareholders reached 23,559 by the end of the reporting period[75]. - The top shareholder, Luo Weiguo, holds 44,520,000 shares, representing 25.78% of the total shares, with all shares pledged[76]. - The company has a total of 10 major shareholders, with the top 10 holding a significant portion of the shares, indicating concentrated ownership[76]. - The total number of shares held by the top 10 shareholders with limited sale conditions is 113,000,000, which is a substantial portion of the company's equity[78]. Corporate Governance and Compliance - The company held two shareholder meetings during the reporting period, ensuring compliance with legal and regulatory requirements[47]. - The company has commitments from major shareholders to not transfer shares for a specified period post-IPO, ensuring stability[50]. - The company has maintained a good integrity status, with no unfulfilled court judgments or significant overdue debts[57]. - The company has not reported any changes in its controlling shareholder or actual controller during the reporting period[79]. - The company has a clear strategy for managing shareholder relationships, particularly with major shareholders being aligned in their actions[77]. Risks and Challenges - The report includes a detailed description of potential risk factors that may affect future plans and strategies[5]. - The company faces risks related to a high proportion of accounts receivable, which could lead to potential bad debt losses if customer payment capabilities deteriorate[42]. - The market competition remains intense, with a risk of declining market share affecting future performance[44]. - The company faced management risks due to expansion, which could weaken market competitiveness if operational adjustments are not made[44]. Social Responsibility and Community Engagement - The company invested CNY 1 million in the Huanglian Township Industrial Poverty Alleviation Fund to promote local tourism development[64]. - A total of CNY 106.24 thousand was allocated for poverty alleviation efforts, including CNY 100 thousand for industrial development and CNY 6.24 thousand for educational support[66]. - The company assisted 1,983 impoverished individuals in achieving poverty alleviation through its initiatives[66]. - The company plans to continue its poverty alleviation efforts in the second half of the year, focusing on vulnerable groups and ecological environment construction[68]. Accounting and Financial Reporting - The financial report has not been audited, but the management has confirmed its accuracy and completeness[4]. - The accounting policies and estimates are in accordance with the relevant enterprise accounting standards, ensuring accurate financial reporting[137]. - The company has not reported any changes in accounting policies or prior period error corrections during this reporting period[127]. - The company recognizes revenue from joint operations based on its share of the output generated from those operations[152]. Future Plans and Strategies - The company plans to leverage PPP opportunities and expand into ecological governance, municipal construction, and tourism planning[30]. - The company aims to enhance its competitive edge by introducing high-caliber talent and expanding its business scope in various sectors[30]. - The company plans to repurchase shares if the stock price remains below the latest audited net asset value for 20 consecutive trading days[52].
天域生物(603717) - 2017 Q1 - 季度财报
2017-04-28 16:00
Financial Performance - Net profit attributable to shareholders reached CNY 23,302,338.95, a significant increase of 167.78% year-on-year[5] - Operating revenue surged by 332.78% to CNY 204,618,837.01 compared to the same period last year[5] - The weighted average return on net assets improved to 3.81%, up 152.48% from -7.26% in the previous year[5] - Operating revenue increased to ¥204,618,837.01, a growth of 332.78% compared to the previous period's ¥47,279,882.03[14] - Operating profit for Q1 2017 was ¥29,091,379.48, recovering from a loss of ¥34,026,499.46 in Q1 2016[26] - Net profit for Q1 2017 was ¥23,284,360.87, compared to a net loss of ¥34,386,432.47 in Q1 2016, indicating a turnaround in profitability[26] Asset and Liability Management - Total assets increased by 37.01% to CNY 2,030,155,365.39 compared to the end of the previous year[5] - Total assets reached ¥2,030,155,365.39, up from ¥1,481,737,139.52, indicating significant growth in the company's asset base[19] - Total liabilities decreased to ¥835,111,726.82 from ¥880,163,961.82, reflecting improved financial stability[20] - Current liabilities decreased to ¥644,682,283.74 in Q1 2017 from ¥698,727,299.23 in Q1 2016, showing improved liquidity management[24] - The company reported a total liability of ¥809,972,659.11 in Q1 2017, down from ¥862,726,484.17 in Q1 2016, indicating a reduction in financial obligations[24] Cash Flow Analysis - Cash flow from operating activities showed a negative net amount of CNY -146,158,228.75, a decline of 746.84% year-on-year[5] - Cash inflow from operating activities was CNY 186,171,714.47, down 20.6% from CNY 234,595,852.48 in the previous period[32] - Net cash outflow from operating activities was CNY 146,158,228.75, compared to a net outflow of CNY 17,259,331.77 in the previous period[33] - Total cash outflow from operating activities was CNY 332,329,943.22, an increase from CNY 251,855,184.25 in the previous period[33] - Cash inflow from financing activities totaled CNY 708,769,285.37, compared to CNY 55,640,000.00 in the previous period[36] Shareholder and Equity Information - The number of shareholders reached 41,949, indicating a growing interest in the company[9] - Shareholders' equity increased to ¥1,195,043,638.57, up from ¥601,573,177.70, demonstrating strong retained earnings growth[20] - Shareholders' equity rose to ¥1,161,373,455.78 in Q1 2017, compared to ¥565,505,554.83 in Q1 2016, indicating strong capital growth[24] Operational Costs and Expenses - Operating costs rose to ¥145,430,302.24, reflecting a 269.27% increase from ¥39,383,062.04 in the prior period[14] - Cash paid for goods and services increased by 41.53% to ¥254,318,055.90, compared to ¥179,694,225.14 in the previous period[14] - Cash paid for various taxes rose by 139.82% to ¥27,963,842.95, up from ¥11,660,393.78, due to increased income tax payments[14] - Operating costs for Q1 2017 were ¥175,466,006.74, up from ¥81,291,901.06 in Q1 2016, reflecting increased operational activities[25] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[25]